Amalgus Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -30.87%
- Profit Growth 38.96%
- Ebitda -18.86%
- Net Worth -43.62%
- Total Assets -12.04%
About Amalgus Biotech
Amalgus Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 June 2019 (Five years and eight months 0 days old ). Its registered office is in Bhopal, Madhya Pradesh, India.
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anchalkumar Srivastava, Vivek Rana, Amresh Srivastava, and One other member serve as directors at the Company.
Company Details
-
Location
Bhopal, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85320MP2019PTC048832
-
Company No.
048832
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Jun 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Amalgus Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anchalkumar Srivastava
|
Director | 10-Jun-2019 | Current |
|
Vivek Rana
|
Director | 10-Jun-2019 | Current |
|
Amresh Srivastava
|
Director | 10-Jun-2019 | Current |
|
Tirdip Ganguli
|
Director | 10-Jun-2019 | Current |
Financial Performance of Amalgus Biotech.
Amalgus Biotech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 30.87% decrease. The company also saw a substantial improvement in profitability, with a 38.96% increase in profit. The company's net worth observed a substantial decline by a decrease of 43.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amalgus Biotech?
Unlock access to Amalgus Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Angi Sons Developers Private LimitedAnchalkumar Srivastava is a mutual person
-
Wastonics India Private Limited
Anchalkumar Srivastava is a mutual person
-
Patna Golf Club
Vivek Rana is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amalgus Biotech?
Unlock and access historical data on people associated with Amalgus Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amalgus Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amalgus Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.